Tiens Biotech Group (USA) Reports Record Twelve-Month Results

Tiens Biotech Group (USA), Inc. (the "Company" or "Tiens", NYSE AlternextUS: TBV), http://www.tiens-bio.com , today announced record financial results for the twelve months ended December 31, 2008.

For the twelve months ended December 31, 2008, revenue was $77.2 million, an increase of 40.7% compared to $54.9 million for the twelve months ended December 31, 2007.

Net income for the twelve months ended December 31, 2008 was $27.7 million, or $0.39 per share, compared to $17.9 million, or $0.25 per share for the twelve months ended December 31, 2007.

Read more: Tiens Biotech Group (USA) Inc ( TBV )

NOVEL FOOD and PARNUTS approval granted for NKO(R) opens the 2nd largest nutraceutical market for Neptune

Neptune Technologies & Bioressources Inc. ("Neptune") (NASDAQ.NEPT - TSX.V.NTB) is pleased to announce today that the European Food Safety Association (EFSA) has approved Neptune Krill Oil (NKO(R)) as a NOVEL FOOD and PARNUTS for commercialization in the European Union.

NKO(R) has successfully passed rigorous regulatory review and scrutiny by all member states of the European Union (EU), which approved NKO(R) as a NOVEL FOOD and PARNUTS allowing its immediate commercialization at a clinically proven effective daily dose in all 27 European countries.

Read more: Neptune Technologies & Biores. ( NTB / NEPT )

CV Technologies Announces Strong Return to Profitability and Double Digit Revenue Growth in Fiscal 2008

CV Technologies Inc. (TSX:CVQ) today announced that revenue for the fiscal year ended September 30, 2008 rose 17.5% to $49.4 million from $42.0 million in fiscal 2007. Net earnings increased to $4.6 million ($0.04 per common share) in fiscal 2008, a $14.4 million improvement from the fiscal 2007 net loss of $9.8 million ($0.09 loss per common share).

"CV Technologies achieved its growth and profitability goals for fiscal 2008, including its publicly stated objective of achieving a double digit sales increase," said Executive Chairman Jack Moffatt. "In fact, we have achieved our key goals in the 12 months since adopting our five-year strategic business plan that addresses all aspects of our business.

Read more: CV Technologies Inc ( CVQ )

GLG Life Tech Corporation Begins Operations at Two New World-Record Stevia Processing Plants; Capacity Up 720% From 2008

GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"), a world leading producer of high quality stevia, announces that it has begun operations at two new stevia processing facilities in China. The facilities, currently the two largest stevia leaf processing centers in the world, are located in the cities of Mingguang (Anhui Province) and Dongtai (Jiangsu Province), China where the company's major stevia leaf growing areas are located. The new plants increase the Company's total raw leaf processing capacity from an existing 5,000 metric tons to 41,000 metric tons, an increase of 720%.

Read more: GLG Life Tech Corporation ( GLG )

Burcon Announces Technology Breakthrough - Introduces New CLARISOY(TM) - Soy Protein Isolate

Burcon NutraScience Corporation (TSX-V: BU) announces today that it has developed a revolutionary soy protein isolate. Burcon has branded this new soy protein isolate as CLARISOY(TM).

CLARISOY(TM) is 100% soluble and transparent in acidic solutions, enabling applications down to pH 2.5. CLARISOY(TM) also has exceptional flavour characteristics and is heat stable permitting hot fill applications. Burcon's CLARISOY(TM) shows great promise for use in a variety of healthy and great tasting food and beverage applications and is expected to be price competitive as well which should be of great interest to food and beverage manufacturers currently dealing with high dairy protein prices.

Read more: Burcon NutraScience Corporation ( BU )

Videos / Webinars

View all videos